Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Balistreri, Carmela R ^a   Buffa, Silvio ^a   Pisano, Calogera ^a   Lio, Domenico ^a   Ruvolo, Giovanni ^a   Mazzesi, Giuseppe ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL MIGRATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; NONHUMAN; PREDICTIVE VALUE; PROGNOSIS; REVIEW; RISK FACTOR; STEM CELL MOBILIZATION; UMBILICAL CORD BLOOD; ANGIOGENESIS; BONE MARROW CELL; CARDIOVASCULAR DISEASES; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; PATHOLOGY; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

BONE MARROW CELLS; CARDIOVASCULAR DISEASES; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 84945555691     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/835934     Document Type: Review

References (80)

1. B. J. North and D. A. Sinclair, "The intersection between aging and cardiovascular disease," Circulation Research, vol. 110, no. 8, pp. 1097-1108, 2012.
2. R. D. Edwards, "Population aging, the dependency burden, and challenges facing preventive medicine," Preventive Medicine, vol. 55, no. 6, pp. 533-534, 2012.
3. P. A. Heidenreich, J. G. Trogdon, O. A. Khavjou et al., "Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association," Circulation, vol. 123, no. 8, pp. 933-944, 2011.
4. L. H. Opie and A. J. Dalby, "Cardiovascular prevention: lifestyle and statins - competitors or companions?" South African Medical Journal, vol. 104, no. 3, pp. 168-173, 2014.
5. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., "Heart disease and stroke statistics - 2015 update: a report from the American Heart Association," Circulation, vol. 131, no. 4, pp. e29-e322, 2015.
6. Institute of Medicine, "Committee on preventing the global epidemic of cardiovascular disease: meeting the challenges in developing countries," in Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health, V. Fuster and B. B. Kelly, Eds., NationalAcademies Press, Washington, DC, USA, 2010.
7. B. J. Gersh, R. D. Simari, A. Behfar, C. M. Terzic, and A. Terzic, "Cardiac cell repair therapy: a clinical perspective," Mayo Clinic Proceedings, vol. 84, no. 10, pp. 876-892, 2009.
8. T. Sadahiro, S. Yamanaka, and M. Ieda, "Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications," Circulation Research, vol. 116, no. 8, pp. 1378-1391, 2015.
9. P. J. Goldschmidt-Clermont, C. Dong, D. M. Seo, and O. C. Velazquez, "Atherosclerosis, inflammation, genetics, and stem cells: 2012 update," Current Atherosclerosis Reports, vol. 14, no. 3, pp. 201-210, 2012.
10. F. H. Cheema, G. Polvani, M. Argenziano, and M. Pesce, "Combining stemcells and tissue engineering in cardiovascular repair - a step forward to derivation of novel implants with enhanced function and self-renewal characteristics," Recent Patents on Cardiovascular Drug Discovery, vol. 7, no. 1, pp. 10-20, 2012.
11. P. Goichberg, J. Chang, R. Liao, and A. Leri, "Cardiac stem cells: biology and clinical applications," Antioxidants & Redox Signaling, vol. 21, no. 14, pp. 2002-2017, 2014.
12. T. Asahara, T. Murohara, A. Sullivan et al., "Isolation of putative progenitor endothelial cells for angiogenesis," Science, vol. 275, no. 5302, pp. 964-967, 1997.
13. T. Resch, A. Pircher, C. M. Kähler, J. Pratschke, and W. Hilbe, "Endothelial progenitor cells: current issues on characterization and challenging clinical applications," Stem Cell Reviews, vol. 8, no. 3, pp. 926-939, 2012.
14. C. Urbich and S. Dimmeler, "Endothelial progenitor cells: functional characterization," Trends in CardiovascularMedicine, vol. 14, no. 8, pp. 318-322, 2004.
15. E. Pelosi, G. Castelli, and U. Testa, "Endothelial progenitors," Blood Cells, Molecules, & Diseases, vol. 52, no. 4, pp. 186-194, 2014.
16. W. Wojakowski, U. Landmesser, R. Bachowski, T. Jadczyk, and M. Tendera, "Mobilization of stem and progenitor cells in cardiovascular diseases," Leukemia, vol. 26, no. 1, pp. 23-33, 2012.
17. A. Schmeisser, C. D. Garlichs, H. Zhang et al., "Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions," Cardiovascular Research, vol. 49, no. 3, pp. 671-680, 2001.
18. S. M. Watt, F. Gullo, M. van der Garde et al., "The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential," British Medical Bulletin, vol. 108, no. 1, pp. 25-53, 2013.
19. F.-J. Lv, R. S. Tuan, K. M. C. Cheung, and V. Y. L. Leung, "Concise review: the surface markers and identity of human mesenchymal stem cells," Stem Cells, vol. 32, no. 6, pp. 1408-1419, 2014.
20. I. R. Murray, C. C. West, W. R. Hardy et al., "Natural history ofmesenchymal stemcells, fromvessel walls to culture vessels," Cellular and Molecular Life Sciences, vol. 71, no. 8, pp. 1353-1374, 2014.
21. D.-W. Li, Z.-Q. Liu, J. Wei, Y. Liu, and L.-S. Hu, "Contribution of endothelial progenitor cells to neovascularization (review)," International Journal of Molecular Medicine, vol. 30, no. 5, pp. 1000-1006, 2012.
22. M. R. Hoenig, C. Bianchi, and F.W. Sellke, "Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis," Current Drug Targets, vol. 9, no. 5, pp. 422-435, 2008.
23. K.A. Gallagher, Z.-J. Liu, M. Xiao et al., "Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α," The Journal of Clinical Investigation, vol. 117, no. 5, pp. 1249-1259, 2007.
24. T. J. Povsic, S. S. Najjar, K. Prather et al., "EPC mobilization after erythropoietin treatment in acute ST-elevationmyocardial infarction: the REVEAL EPC substudy," Journal of Thrombosis and Thrombolysis, vol. 36, no. 4, pp. 375-383, 2013.
25. H. Ito, I. I. Rovira, M. L. Bloom et al., "Endothelial progenitor cells as putative targets for angiostatin," Cancer Research, vol. 59, no. 23, pp. 5875-5877, 1999.
26. K. Williamson, S. E. Stringer, and M. Y. Alexander, "Endothelial progenitor cells enter the aging arena," Frontiers in Physiology, vol. 3, article 30, 2012.
27. F. Felice, M. C. Barsotti, P. Poredos, A. Balbarini, and R. Di Stefano, "Effect of aging on metabolic pathways in endothelial progenitor cells," Current Pharmaceutical Design, vol. 19, no. 13, pp. 2351-2365, 2013.
28. C.-P. Lin, F.-Y. Lin, P.-H. Huang et al., "Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation," BioMed Research International, vol. 2013, Article ID 845037, 10 pages, 2013.
29. B. K. Rodiño-Janeiro, B. Paradela-Dobarro, M. I. Castiñeiras- Landeira, S. Raposeiras-Roubín, J. R. González-Juanatey, and E. Alvarez, "Current status of NADPH oxidase research in cardiovascular pharmacology, "VascularHealth and RiskManagement, vol. 9, no. 1, pp. 401-428, 2013.
30. N. Werner and G. Nickenig, "Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?" Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 2, pp. 257-266, 2006.
31. C. de Ciuceis, A. Pilu, C. Cappelli et al., "Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism," Journal of Endocrinological Investigation, vol. 34, no. 5, pp. 335-339, 2011.
32. S. K. A. Shakoor, A. Aldibbiat, L. E. Ingoe et al., "Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy," The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 1, pp. 319-322, 2010.
33. G. P. Fadini, S. de Kreutzenberg, M. Albiero et al., "Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 997-1004, 2008.
34. J. Sugawara, M. Mitsui-Saito, T. Hoshiai, C. Hayashi, Y. Kimura, and K. Okamura, "Circulating endothelial progenitor cells during human pregnancy, "TheJournal of Clinical Endocrinology & Metabolism, vol. 90, no. 3, pp. 1845-1848, 2005.
35. P. S. Lee and K. K. Poh, "Endothelial progenitor cells in cardiovascular diseases, "World Journal of Stem Cells, vol. 6, no. 3, pp. 355-366, 2014.
36. J. M. Fernández, D. Rosado- Álvarez, M. E. da Silva Grigoletto et al., "Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome," Clinical Science, vol. 123, no. 6, pp. 361-373, 2012.
37. C. Marin, R. Ramirez, J. Delgado-Lista et al., "Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium," The American Journal of Clinical Nutrition, vol. 93, no. 2, pp. 267-274, 2011.
38. W. C. Aird, "Endothelium in health and disease," Pharmacological Reports, vol. 60, no. 1, pp. 139-143, 2008.
39. S. H. van Ierssel, P. G. Jorens, E. M. van Craenenbroeck, and V. M. Conraads, "The endothelium, a protagonist in the pathophysiology of critical illness: focus on cellular markers," BioMed Research International, vol. 2014, Article ID 985813, 10 pages, 2014.
40. G. Favero, C. Paganelli, B. Buffoli, L. F. Rodella, and R. Rezzani, "Endothelium and its alterations in cardiovascular diseases: life style intervention," BioMed Research International, vol. 2014, Article ID 801896, 28 pages, 2014.
41. E. Shantsila, T. Watson, and G. Y. H. Lip, "Endothelial progenitor cells in cardiovascular disorders," Journal of the American College of Cardiology, vol. 49, no. 7, pp. 741-752, 2007.
42. T. F. J. King and J. H. McDermott, "Endothelial progenitor cells and cardiovascular disease," Journal of Stem Cells, vol. 9, no. 2, pp. 93-106, 2014.
43. S. Obi, K. Yamamoto, and J. Ando, "Effects of shear stress on endothelial progenitor cells," Journal of Biomedical Nanotechnology, vol. 10, no. 10, pp. 2586-2597, 2014.
44. F. Ma, A. Morancho, J. Montaner, and A. Rosell, "Endothelial progenitor cells and revascularization following stroke," Brain Research, 2015.
45. J.M. Hill, G. Zalos, J. P. J. Halcox et al., "Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, "The New England Journal of Medicine, vol. 348, no. 7, pp. 593-600, 2003.
46. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., "Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function," Nature Medicine, vol. 7, no. 4, pp. 430-436, 2001.
47. A. Kawamoto, T. Asahara, and D.W. Losordo, "Transplantation of endothelial progenitor cells for therapeutic neovascularization," Cardiovascular RadiationMedicine, vol. 3, no. 3-4, pp. 221-225, 2002.
48. D. Orlic, J. Kajstura, S. Chimenti, D. M. Bodine, A. Leri, and P. Anversa, "Bone marrow stem cells regenerate infarcted myocardium," Pediatric Transplantation, vol. 7, no. 3, pp. 86-88, 2003.
49. K. Naruse, Y. Hamada, E. Nakashima et al., "Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy," Diabetes, vol. 54, no. 6, pp. 1823-1828, 2005.
50. W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, C.-Y. Su, and H. Li, "Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing β1 integrin-mediated angiogenesis in chronic stroke rats, "TheJournal ofNeuroscience, vol. 26, no. 13, pp. 3444-3453, 2006.
51. J. Gómez-Navarro, J. L. Contreras, W. Arafat et al., "Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model," Gene Therapy, vol. 7, no. 1, pp. 43-52, 2000.
52. M. Ohtsuka, H. Takano, Y. Zou et al., "Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization," The FASEB Journal, vol. 18, no. 7, pp. 851-853, 2004.
53. B. E. Strauer, M. Brehm, T. Zeus et al., "Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans," Circulation, vol. 106, no. 15, pp. 1913-1918, 2002.
54. B. Assmus, V. Schächinger, C. Teupe et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)," Circulation, vol. 106, no. 24, pp. 3009-3017, 2002.
55. F. Fernández-Avilés, J. A. San Román, J. García-Frade et al., "Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction," Circulation Research, vol. 95, no. 7, pp. 742-748, 2004.
56. V. Schächinger, B. Assmus, M. B. Britten et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCAREAMI trial," Journal of the American College of Cardiology, vol. 44, no. 8, pp. 1690-1699, 2004.
57. D. M. Leistner, U. Fischer-Rasokat, J. Honold et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy," Clinical Research in Cardiology, vol. 100, no. 10, pp. 925-934, 2011.
58. M. Gennari, E. Gambini, B. Bassetti, M. Capogrossi, and G. Pompilio, "Emerging treatment options for refractory angina pectoris: ranolazine, shock wave treatment, and cell-based therapies," Reviews in CardiovascularMedicine, vol. 15, no. 1, pp. 31-37, 2014.
59. J. Tongers and D. W. Losordo, "Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells," Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2843-2852, 2007.
60. H.-F. Tse, Y.-L. Kwong, J. K. F. Chan, G. Lo, C.-L. Ho, and C.-P. Lau, "Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation," The Lancet, vol. 361, no. 9351, pp. 47-49, 2003.
61. K. Hamano, M. Nishida, K. Hirata et al., "Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results," Japanese Circulation Journal, vol. 65, no. 9, pp. 845-847, 2001.
62. E. C. Perin, H. F. R. Dohmann, R. Borojevic et al., "Transendocardial, autologous bonemarrow cell transplantation for severe, chronic ischemic heart failure," Circulation, vol. 107, no. 18, pp. 2294-2302, 2003.
63. E. Tateishi-Yuyama, H. Matsubara, T. Murohara et al., "Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial," The Lancet, vol. 360, no. 9331, pp. 427-435, 2002.
64. S. Matoba, T. Tatsumi, T. Murohara et al., "Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia," AmericanHeart Journal, vol. 156, no. 5, pp. 1010-1018, 2008.
65. K. Yamamoto, T. Kondo, S. Suzuki et al., "Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 12, pp. e192-e196, 2004.
66. K. Lenk, V. Adams, P. Lurz et al., "Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia," European Heart Journal, vol. 26, no. 18, pp. 1903-1909, 2005.
67. S. Erbs, A. Linke, V. Adams et al., "Transplantation of bloodderived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study," Circulation Research, vol. 97, no. 8, pp. 756-762, 2005.
68. J. D. Pearson, "Endothelial progenitor cells - hype or hope?" Journal of Thrombosis and Haemostasis, vol. 7, no. 2, pp. 255-262, 2009.
69. K. Yamahara and H. Itoh, "Potential use of endothelial progenitor cells for regeneration of the vasculature," Therapeutic Advances in Cardiovascular Disease, vol. 3, no. 1, pp. 17-27, 2009.
70. A. Siddique, E. Shantsila, G. Y. Lip, and C. Varma, "Endothelial progenitor cells: what use for the cardiologist?" Journal of Angiogenesis Research, vol. 2, article 6, 2010.
71. E. Pasquier and S. Dias, "Endothelial progenitor cells: hope beyond controversy," Current Cancer Drug Targets, vol. 10, no. 8, pp. 914-921, 2010.
72. R. Madonna and R. De Caterina, "Circulating endothelial progenitor cells: do they live up to their name?" Vascular Pharmacology, vol. 67-69, pp. 2-5, 2015.
73. E. M. Van Craenenbroeck, A. H. Van Craenenbroeck, S. Van Ierssel et al., "Quantification of circulating CD34+/KDR+/ CD45dim endothelial progenitor cells: analytical considerations," International Journal of Cardiology, vol. 167, no. 5, pp. 1688-1695, 2013.
74. L. C. Lee, C.-S. Chen, P.-F. Choong, A. Low, H. C. Tan, and K. K. Poh, "Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics," International Journal of Cardiology, vol. 142, no. 2, pp. 199-201, 2010.
75. M. Hristov and C. Weber, "Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance," Journal ofCellular and MolecularMedicine, vol. 8, no.4, pp. 498-508, 2004.
76. R. J. Medina, C. L. O'Neill, M. Sweeney et al., "Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities," BMC Medical Genomics, vol. 3, article 18, 2010.
77. D. P. Sieveking, A. Buckle, D. S. Celermajer, and M. K. C. Ng, "Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay," Journal of the American College of Cardiology, vol. 51, no. 6, pp. 660-668, 2008.
78. D. G. Duda, K. S. Cohen, D. T. Scadden, and R. K. Jain, "A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood," Nature Protocols, vol. 2, no. 4, pp. 805-810, 2007.
79. N. M. Kane, Q. Xiao, A. H. Baker, Z. Luo, Q. Xu, and C. Emanueli, "Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation)," Pharmacology and Therapeutics, vol. 129, no. 1, pp. 29-49, 2011.
80. J. He, Z. Xiao, X. Chen et al., "The expression of functional tolllike receptor 4 is associated with proliferation and maintenance of stem cell phenotype in endothelial progenitor cells (EPCs)," Journal of Cellular Biochemistry, vol. 111, no. 1, pp. 179-186, 2010.